ARCHIVES

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

Proposed Guidelines For Clinical Tests Of Oncologic Drugs

November 28, 1975

NIH Funding Strategies, UICC Fellowships

December 4, 1992

Comprehensive Centers Balk At “Requiring” All Control Programs To Be Funneled Through Them

December 5, 1975

Ford Asks NCAB for Scientific Basis For Regulation Of Tar and Nicotine Content Of Cigarettes By Dec.

October 25, 1974

ACS Ask Stronger Federal Action Against Cigarettes

November 23, 1979